Pharmaceuticals
PRESENTASI TIM
MUTU
.
UPTD PUSKESMAS KEC .SUKOREJO
TAHUN 2019 PRESENTASI
TIM MUTU DAN AUDIT INTERNAL
Contoso
Pharmaceuticals
page 2
PENDAHULUAN
Contoso
Pharmaceuticals
page 4
Sistem Manajemen & Instrumen Akreditasi di Puskesmas (Versi
2016)
SUBSISTEM SUBSISTEM
SUBSISTEM SUBSISTEM
SUBSISTEM
SUBSISTEM
SMM SMP
PUSKESMAS
INSTRUMEN AKREDITASI
PUSKESMAS VERSI 2016
Contoso
BAB 3.6.9 BAB 1.2.4.5.7.8 Pharmaceuticals
WILAYAH IMPLEMENTASI SISTEM
KEPALA
PUSKESMAS
SMM
TIM MANAJEMEN
MUTU Kasubag
TU
Contoso
Pharmaceuticals
IDEALNYA AGAR TERBENTUK SISTEM (PDCA) MAKA PERLU DILAKUKAN MONITORING,RTL,EVALUASI
AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY
2020 2021
Dokumen Rencana
Program
Peningkatan Mutu &
Keselamatan Pasien
Manajemen Mutu
STRUKTUR & HIRARKI TIM
DALAM MANAJEMEN MUTU
page 11
.
Contoso
Pharmaceuticals
PELAPORANYANG MASUK 2019
• AIR PUSTU SUKOREJO
• ASBES POLI GIGI JEBOL
Contoso
Pharmaceuticals
page 13
Tim AUDIT INTERNAL
Contoso
Pharmaceuticals
DASAR PENGUKURAN INDIKATOR MUTU
Contoso
Pharmaceuticals
page 20
Keberhasilan sistem mutu/Sistem manejemen puskesmas :
Contoso
Pharmaceuticals
page 21
• Mengusulkan Rencana usulan Pelatihan
K3,KPP,PPI,
• Pelaporan KPP agar segera ditindak lanjuti
MASUKAN TIM MUTU
• Bersama sama mulai membangun sistem Summary tagline or
manejemen dengan memulai pengukuran sub-headline
indikator, minlok,linsek,rtl
• Masih proses perbaikan menerima masukan
Contoso
Pharmaceuticals
page 22
TERIMAKSIH
UPTD PUSKESMAS KEC SUKOREJO
Contoso
Pharmaceuticals
page 23
Contoso
Pharmaceuticals
page 24
Contoso
Pharmaceuticals
page 25
Contoso
Pharmaceuticals
page 26
Emphasize your
main benefit
Other benefits include
• Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
• Nunc tempus, risus sodales hendrerit,
arcu dolor commodo libero. Contoso
Pharmaceuticals
page 27
Business Model
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Contoso
Pharmaceuticals
page 28
Unique First to Market
Lorem ipsum dolor sit Etiam aliquet eu mi.
amet, consectetur Ut fermentum a
adipiscing elit. magna ut eleifend.
Product
Lorem ipsum dolor sit amet,
consectetur adipiscing elit.
Tested Authentic Etiam aliquet eu mi quis.
Integer convallis Suspendisse sit amet
suscipit eu varius.
Morbi a purus dolor.
ipsum varius finibus
justo viverra blandit.
Contoso
Pharmaceuticals
page 29
Market Opportunity Option 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
$1B $2B
• Lorem ipsum dolor sit amet, • Ut congue quis tortor eget
consectetur adipiscing elit. sodales. Nulla a erat eget
nunc hendrerit ultrices eu nec
• Etiam aliquet eu mi quis
nulla.
lacinia. Ut fermentum a
magna ut eleifend. Integer • Donec viverra leo aliquet,
convallis suscipit ante eu auctor quam id, convallis orci.
varius.
• Morbi a purus dolor.
Suspendisse sit amet ipsum
finibus justo viverra blandit.
Contoso
Pharmaceuticals
page 30
Market Opportunity Option 2
Integer convallis suscipit ante eu varius. Morbi a purus dolor.
$3B
Opportunity to Build
$2B
Freedom to Invent
$1B
Few Competitors
Lorem ipsum dolor sit Etiam aliquet eu mi quis Integer convallis suscipit
amet, consectetur lacinia. Ut fermentum a ante eu varius. Morbi a
adipiscing elit. magna ut eleifend. purus dolor.
Contoso
Pharmaceuticals
page 31
Competition Option 2
Convenience
Contoso
Pharmaceuticals
Expensive Affordable
Inconvenient Contoso
Pharmaceuticals
page 32
Traction
Forecasting for success
20YY 0 0 $0 $0 $250,000
$200,000
20YY 10 100 $6,750 $1,013
$150,000
20YY 50 500 $33,750 $5,063
$100,000
page 33
Financials
Year 1 Year 2 Year 3
Detailers 5,000 40,000 160,000
Users 50,000 400,000 1 600,000
Sales 500,000 4 000,000 16 000,000
Average Price per Sale 75 80 90
Revenue @ 15% 5 625,000 48 000,000 216 000,000
• Cost of Revenue 0 0 0
Gross Profit 5 625,000 48 000,000 216 000,000
Expenses
• Sales & Marketing 5 062,500 38 400,000 151 200,000 70%
• Customer Service 1 687,500 9 600,000 21 600,000 10%
• Product
Development 562,500 2 400,000 10 800,000 5%
• Research 281,250 2 400,000 4 320,000 2%
Total Expenses 7 593,750 52 800,000 187 920,000
Contoso
EBIT -1 968,750 -4 800,000 28 080,000 13% Pharmaceuticals
page 34
Keberhasilan sistem mutu/Sistem manejemen puskesmas :
Contoso
Pharmaceuticals
page 35
Funding
$32,000
$82,000
page 36
• Lorem ipsum dolor sit amet, consectetur
adipiscing elit. Etiam aliquet eu mi quis
lacinia. Summary
• Ut fermentum a magna ut eleifend. Integer
convallis suscipit ante eu varius. Morbi a
Summary tagline or
purus dolor. Suspendisse sit amet ipsum sub-headline
finibus justo viverra blandit.
• Ut congue quis tortor eget sodales. Nulla a
erat eget nunc hendrerit ultrices eu. Contoso
Pharmaceuticals
page 37
Thank You
April Hansson
+1 23 987 6554
april@contoso.com
Contoso
Pharmaceuticals
www.contoso.com
page 38
Presentation Cover
Option 2
Lorem ipsum dolor sit amet,
Contoso
consectetur adipiscing elit. Pharmaceuticals
page 39
Customize this Template
Template Editing
Instructions and Feedback
Contoso
Pharmaceuticals
page 40